Ratings changes for Plug Power, Meta Platforms, Robinhood Markets, X-Energy, Silver Standard Resources, Enphase Energy, Workday and more...

October 14th, 2026

Unsubscribe
 
 
MarketBeat Daily RatingsMy Portfolio
 

Today's Top Stories

Tesla Wants to Make Its Own Chips—What Could Go Wrong?

Tesla Wants to Make Its Own Chips—What Could Go Wrong?

By Sam Quirke

PBF Energy's Stunning Rally Faces a Critical Test

PBF Energy's Stunning Rally Faces a Critical Test

By Peter Frank

How a Hurricane Could Help Some Refineries—and Hurt Others

How a Hurricane Could Help Some Refineries—and Hurt Others

By Nathan Reiff

Palantir Micron and SanDisk Show a Familiar Pattern

Sponsored · Partner Content

The 7 Stocks Quietly Gaining Attention Right Now

Palantir, Micron and SanDisk show how fast a stock can become the trade everyone suddenly wants. That's often when investors make their costliest mistake: arriving after the easy part of the move is gone. A new premium eBook flags 7 stocks that may be worth knowing about before the broader crowd catches on. You don't need to buy any of them - just knowing what's quietly gaining attention can be useful…

See the 7 stocks on the watchlist while it's still freetc pixel

Analysts' Upgrades

All Upgrades
ALB Albemarle
Mizuho
Neutral → Outperform
PT $130.00
32.8% upside
EAT Brinker International
Jefferies Financial Group
Hold → Buy
PT $230.00 → $255.00
24.7% upside
GXO GXO Logistics
The Goldman Sachs Group
Neutral → Buy
PT $61.00
33.1% upside
LQDA Liquidia
BTIG Research
Neutral → Buy
PT $70.00
106.2% upside
Lifesci Capital
Market Perform → Outperform
PT $59.00
73.8% upside
NGLOY Anglo American
JPMorgan Chase & Co.
Underweight → Neutral
WU Western Union
Monness Crespi & Hardt
Sell → Neutral
WY Weyerhaeuser
Bank of America
Neutral → Buy
PT $28.00 → $25.00
32.3% upside

Microscopic footage reveals immune cells destroying cancer cells

Sponsored · Partner Content

Microscopic footage reveals immune cells destroying cancer cells

Time-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer cells - and early human data revealed up to a 63.7 percent reduction in cancer burden. One NASDAQ-listed biotech's TriKE platform is designed to keep these immune cells locked onto tumors longer. Its next-generation version, showing potential for 10 to 40 times greater potency…

Watch the microscopic footage and learn about the next catalysttc pixel

Analysts' Downgrades

All Downgrades
HPE Hewlett Packard Enterprise
Barclays
Overweight → Equal Weight
PT $83.00 → $77.00
21.8% upside
LII Lennox International
The Goldman Sachs Group
Buy → Neutral
PT $547.00 → $390.00
11.7% upside

Forbes calls this a

Sponsored · Partner Content

Forbes calls this a "golden era" for retirement income

Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the eye-popping yields are fueling a boom among everyday investors. Three years ago, barely a dozen of these funds existed - today there are more than 100, holding over $140 billion. These funds trade on the NYSE and NASDAQ and are built to generate monthly income…

Watch the short briefing to see how this income approach workstc pixel

Analysts' New Coverage

All Initiations
AGNT Exp World
Citizens Jmp
Market Outperform
PT $6.00
60.9% upside
CHH Choice Hotels International
Freedom Broker
Buy
PT $117.00
13.5% upside
COMP Compass
Citizens Jmp
Market Outperform
PT $11.00
25.8% upside
DOUG Douglas Elliman
Citizens Jmp
Market Perform
ENTG Entegris
Truist Financial
Buy
PT $190.00
24.1% upside
GIC Global Industrial
Freedom Broker
Hold
PT $39.00
10.8% downside
GRMN Garmin
Arete Research
Buy
PT $335.00
19.9% upside
H Hyatt Hotels
Freedom Broker
Buy
PT $192.00
19.8% upside
HLT Hilton Worldwide
Freedom Broker
Buy
PT $359.00
9.5% upside
IDYA IDEAYA Biosciences
Stifel Nicolaus
Buy
PT $48.00
41.8% upside
JSPR Jasper Therapeutics
William Blair
Outperform
KEX Kirby
JPMorgan Chase & Co.
Overweight
PT $200.00
45.1% upside
MAR Marriott International
Freedom Broker
Buy
PT $408.00
9.7% upside
Q Qnity Electronics
Truist Financial
Buy
PT $170.00
40.0% upside
RCUS Arcus Biosciences
JPMorgan Chase & Co.
Overweight
PT $41.00
82.0% upside
REAX Real REMAX Group
Citizens Jmp
Market Outperform
PT $40.00
194.1% upside
SLGL Sol-Gel Technologies
Cantor Fitzgerald
Overweight
SPTX Seaport Therapeutics
Canaccord Genuity Group
Buy
PT $28.00
67.9% upside
SXI Standex International
JPMorgan Chase & Co.
Neutral
PT $320.00
16.9% upside
USAS Americas Gold and Silver
Stifel Nicolaus
Buy
WH Wyndham Hotels & Resorts
Freedom Broker
Buy
PT $88.00
21.5% upside

Trump goes

Sponsored · Partner Content

Trump goes "all-in" on Grand Canyon energy breakthrough

A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits…

See the ticker behind this Grand Canyon energy breakthrough nowtc pixel
Premium research

Exclusive reports, members only

Get in-depth research reports on emerging industries and market trends, written just for MarketBeat All Access subscribers.

Get Full Report Access

More Stories

Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen

Don’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could Deepen

By Thomas Hughes

Amazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?

Amazon's $220 Billion AI Bet Is Getting Bigger—Can Earnings Justify the Spending?

By Sam Quirke

Earnings Season Could Make Millionaires (6 Stocks to Watch)

Earnings Season Could Make Millionaires (6 Stocks to Watch)

Thank you for subscribing to MarketBeat!
MarketBeat empowers everyday investors to make better investment decisions by offering up-to-the-minute financial information and unbiased investment analysis.
 
If you have questions about your subscription, please feel free to email our U.S. based support team at contact@marketbeat.com.
 
If you wish to opt out or update which newsletters you subscribe to, you can update your email preferences or unsubscribe from these emails.
 
Copyright 2006-2026 MarketBeat Media, LLC. All rights protected.
345 N Reid Place, Sixth Floor, Sioux Falls, S.D. 57103. USA..
 
Featured Link: Microscopic footage reveals immune cells destroying cancer cells (From Market Tactic)